XML 91 R72.htm IDEA: XBRL DOCUMENT v3.25.0.1
Loans Receivable and Allowance for Credit Losses - Narrative (Details)
$ in Thousands
 12 Months Ended
May 16, 2024
USD ($)
Dec. 31, 2024
USD ($)
loan
Dec. 31, 2023
USD ($)
loan
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Loans held for sale   $ 162,453 $ 1,785    
Accrued interest on loans   78,500 50,900    
Loans held for investment   18,659,370 10,871,916    
Prepayments and normal amortization, interest income decreased   314 206 $ 270  
Non-accrual   $ 72,061 $ 49,639    
Number of loans accruing interest 90 days or greater | loan   0 0    
Increase in interest income   $ 2,800 $ 1,600 1,000  
Provision charge for credit losses on loans   83,604 27,900 8,400  
Allowance for credit loss   (193,432) (107,200) (88,023) $ (80,740)
Impaired loan defined floor limit (greater than)   $ 1,000      
Impaired loans number | loan   26      
Impaired loans   $ 55,400      
Total stockholders’ equity   2,601,207 1,690,596 1,597,703 1,697,096
Allowance for credit losses on PCD loans   17,188 0 0  
Financial Asset Acquired with Credit Deterioration          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Loans held for investment   620,400 165,100    
Allowance for credit loss   (15,200) (1,700)    
Retained Earnings          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Total stockholders’ equity   989,111 974,542 918,158 814,533
Cumulative Effect, Period of Adoption, Adjustment          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Allowance for credit loss     0 594 $ 0
Total stockholders’ equity       433  
Cumulative Effect, Period of Adoption, Adjustment | Retained Earnings          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Total stockholders’ equity       433  
Special Reserves          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Impaired loans with related specific reserves   7,500      
Real Estate | Commercial Loan          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Loans measured for impairment based on the fair value of the underlying collateral   11,000 24,100    
Lakeland Bancorp, Inc. - Merger Agreement          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Allowance for credit loss   (60,100)      
Allowance for credit losses on PCD loans $ 17,188        
Director          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Loans held for investment   98,800      
Executive Officer          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Loans held for investment   3,500      
Commercial loans          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Loans held for sale   151,300      
Non-accrual   24,243 41,487    
Provision charge for credit losses on loans   20,011 11,159    
Allowance for credit loss   (43,642) $ (31,475) (27,413)  
Allowance for credit losses on PCD loans   $ 6,070      
Commercial loans | Cumulative Effect, Period of Adoption, Adjustment          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Allowance for credit loss       $ 43